Due to the Split 2:1, in Novo Nordisk A/S (NOVO B, DK0010280817), OMX Derivatives Markets will act and adjust NOVO B in accordance to the “Guidelines for Calculation of the OMXC20 Index”, rule 5.2. On the ex-day December 3, 2007 the number of shares for NOVO B in OMXC20 index will be increased to 566 432 800 shares. For further information concerning this exchange notice please contact Ida Gustavsson or Erik Hågemo, telephone +46 8 405 60 00 OMX Derivatives Markets Ida Gustavsson Erik Hågemo Index Manager Junior Index Analyst